Maximum Dose of Phenytoin in Status Epilepticus
The maximum dose of phenytoin for status epilepticus is 20 mg/kg, with a maximum initial dose of 1000 mg, administered at a rate not exceeding 50 mg/minute in adults and 1-3 mg/kg/minute (or 50 mg/minute, whichever is slower) in pediatric patients. 1, 2
Dosing Guidelines
Initial Loading Dose:
Administration Rate:
- Adults: Not exceeding 50 mg/minute 2
- Children: Not exceeding 1-3 mg/kg/minute or 50 mg/minute, whichever is slower 1, 2
Repeat Dosing:
- If seizures continue, an additional dose may be given after 15 minutes, with a maximum total dose of 40 mg/kg 1
- Maintenance doses of 100 mg IV every 6-8 hours should follow the loading dose 2
Administration Considerations
IV Administration Requirements:
- Administer directly into a large peripheral or central vein through a large-gauge catheter 2
- Dilute in normal saline (NOT dextrose solutions) 1, 2
- Test IV catheter patency with sterile saline flush before and after administration 2
- Continuous cardiac monitoring is essential during administration 2
Safety Precautions:
- Monitor heart rate continuously - reduce infusion rate if heart rate decreases by 10 beats per minute 1
- Monitor blood pressure continuously with an arterial line if possible 2
- Be prepared to provide respiratory support due to increased risk of apnea when combined with other sedative agents 1
Efficacy and Adverse Effects
Efficacy:
- In randomized controlled trials, phenytoin alone has shown a 44% success rate in terminating status epilepticus within 20 minutes 1
- When used after benzodiazepines, phenytoin has shown efficacy rates of 84% in some studies 1
Common Adverse Effects:
- Hypotension (occurs in approximately 12% of patients) 1
- Cardiac arrhythmias, especially with rapid infusion 1, 2
- Local irritation at injection site 2
- Respiratory depression 1
Alternative Considerations
If fosphenytoin is available, it is preferred over phenytoin due to:
- Lower risk of adverse cardiac effects 1
- Faster administration rates possible (150 mg PE/minute) 1
- Fewer local injection site reactions 1
Monitoring
- Therapeutic serum levels: 10-20 mcg/mL total phenytoin (1-2 mcg/mL unbound phenytoin) 2
- In patients with renal or hepatic disease or hypoalbuminemia, monitor unbound phenytoin concentrations 2
- Continuous EEG monitoring is recommended in refractory cases 3
Important Cautions
- Neonates have an increased risk of toxicity due to decreased protein binding; phenobarbital is preferred in this population 1
- Reduce dosage in patients with hepatic or renal impairment 2
- Never administer intramuscularly for status epilepticus due to erratic absorption and risk of tissue necrosis 2
- If 50% QRS widening or significant hypotension occurs during administration, hold the remainder of the dose 1